Als vor etwas über 20 Jahren die Standortentscheidung der Gemeinnützigen Hertie-Stiftung fiel, war dies ein außerordentlicher Glücksfall für die Universität Tübingen. Mit dem Hertie-Institut für klinische Hirnforschung haben wir eine beispielhafte Einrichtung von höchstem Renommee vor Ort, die maßgeblich dazu beitrug, Tübingen international als eine Top-Adresse für Hirnforschung bekannt zu machen.
Prof. Dr. Bernd Engler
Rektor Universität Tübingen
Bild: U. Metz/Universität TübingenDas Hertie-Institut für klinische Hirnforschung steht für die Exzellenz des Wissenschaftsstandortes Tübingen. Nur gemeinsam konnten Universität und Institute im nationalen Wettbewerb auf Spitzenplätze vorstoßen. Auch städtebaulich ist das Institut eine Zierde. Grund also stolz und dankbar zu sein angesichts der Leistungen der ersten 20 Jahre. Ad multos annos!
Boris Palmer
Oberbürgermeister Tübingen
Bild: Manfred GroheDas Hertie-Institut für klinische Hirnforschung ist die wichtigste Initiative innerhalb unseres Bereiches Gehirn erforschen. Ich gratuliere im Namen der Stiftung zu 20 Jahren Spitzenforschung.
Dr. Frank-Jürgen Weise
Vorstandsvorsitzender der Gemeinnützigen Hertie-Stiftung
Bild: Hertie-Stiftung/Marck KrauseDas Zentrum für Neurologie ist Vorreiter für eine erfolgreich gelebte Translation in der Neuromedizin und hat damit eine hohe Vorbildfunktion für die Bundesrepublik. Das hat der Wissenschaftsrat in seiner Stellungnahme 2015 gewürdigt.
Prof. Dr. Hans-Jochen Heinze
HIH-Kuratoriumsvorsitzender
Bild: Melitta Schubert/Universitätsmedizin MagdeburgKlinisch innovative Forschung, bereichernde translationale und interdisziplinäre Zusammenarbeit und gelebte Weltoffenheit in einer für eine Familie äußerst lebenswerten schwäbischen Kleinstadt – ich habe sehr positive Erinnerungen an meine Zeit am HIH. Das HIH bietet besonders umfassende Möglichkeiten einer ärztlich-wissenschaftlichen Berufung nachzugehen und den persönlichen Weg zu finden.
Prof. Dr. Daniela Berg
Direktorin der Klinik für Neurologie, Kiel
Bild: UKSHDas HIH bietet ein exzellentes Umfeld und eine erstklassige Infrastruktur, um erfolgreich molekulare Mechanismen neurodegenerativer Erkrankungen zu erforschen. Die gelebte interdisziplinäre Zusammenarbeit mit den Kolleginnen und Kollegen, welche ich von der ersten Stunde an erleben durfte, haben den Grundstein für meine Laufbahn in der translationalen Biomedizin gelegt. Herzlichen Glückwunsch zum Jubiläum!
Prof. Dr. Rejko Krüger
Director of Transversal Translational Medicine, Luxembourg Institute of Health
Bild: OlivimagesDas HIH ist für mich ein einzigartiger Ort für Spitzenforschung – und hat mir zudem gezeigt, wie wichtig es ist, interdisziplinär zu denken und seine Erkenntnisse auf packende Art mit der Welt zu teilen.
Dr. Henning Beck
Neurowissenschaftler, Science Slammer & Wissenschaftsautor
Bild: PrivatMeine Begeisterung zur Mathematik wurde in meiner Zeit als Doktorandin am Hertie-Institut zur Leidenschaft, komplexe neurologische Prozesse zu verstehen. Dies wurde mir, wie auch so vielen anderen Nachwuchswissenschaftler*innen, unter anderem auch durch die Unterstützung und exzellente Infrastruktur des Instituts ermöglicht. Ich gratuliere herzlich zum 20jährigen Jubiläum!
Dr. Daniela Vallentin
Forschungsgruppenleiterin, MPI für Ornithologie
Bild: PrivatEinen Zustand kann man ändern – Durch langjährige und sehr umfangreiche Hirnforschung am HIH und dem Zentrum für Neurologie wurde eine spezielle Therapiemethode entwickelt, welche mir nach meinem Schlaganfall geholfen hat, wieder den Weg zurück ins ‚normale‘ Leben zu finden. Beruflich integriert – gesellschaftlich etabliert.
Sandra Friesch
Ehemalige Patientin
Bild: Verena Müller / UKTIch gratuliere dem Hertie-Institut zum 20-jährigen Bestehen auf das Herzlichste! Die exzellenten Leistungen des Instituts kommen Patientinnen und Patienten unmittelbar zugute, und deshalb unterstützen wir von Seiten des Landes Baden-Württemberg die Arbeit des Instituts aus Überzeugung. Das Institut leistet wertvolle Beiträge für die Medizinforschung im Land und ich bin gespannt auf die Resultate in Forschung und Translation, die wir in den kommenden Jahren vom Hertie Institut erwarten dürfen.
Theresia Bauer
MdL, Ministerin für Wissenschaft, Forschung und Kunst Baden-Württemberg
Bild: Sabine ArndtMit der Errichtung des Hertie-Instituts für klinische Hirnforschung wurde vor 20 Jahren der Grundstein für den Tübinger Neurocampus gelegt. Das war ein wichtiger erster Schritt für die heute hervorragende neurologische Grundlagenforschung, translationale Forschung und klinische Anwendung. Durch die Verzahnung von Forschung und Krankenversorgung ist das HIH am Standort Tübingen ein entscheidender Mehrwert für unsere neurologischen Patientinnen und Patienten. Herzlichen Glückwunsch zu 20 Jahren HIH!
Prof. Dr. Michael Bamberg
Leitender Ärztlicher Direktor Universitätsklinikum Tübingen
Bild: Verena Müller / UKTDie enge Zusammenarbeit von Grundlagenwissenschaftlern und Klinikern auf dem Tübinger Neurocampus ermöglicht eine rasche Umsetzung neuer Diagnose- und Therapieverfahren in die Praxis – dank dieses Erfolgsmodells konnte sich der Standort Tübingen zu einem Leuchtturm der Neurologischen Forschung entwickeln. Die Medizinische Fakultät gratuliert dem HIH zum 20-jährigen Bestehen und freut sich auf die weitere Zusammenarbeit.
Prof. Dr. Bernd Pichler
Dekan Medizinische Fakultät Tübingen
Bild: Universität Tübingen
News
-
Tübingen researchers aim to alleviate paralysis after stroke with personalized brain stimulation
A new multicenter study led by Prof. Ulf Ziemann receives funding of 1.6 million euros
-
Protein changes in the liquor indicate inflammatory processes in the brain
They could provide information about inflammatory processes in diseases such as Alzheimer's or Parkinson's as biomarkers, report HIH researchers.
-
June 8 is World Brain Tumor Day
To mark the occasion, Prof. Dr. Dr. Ghazaleh Tabatabai explains in an interview with the Hertie Foundation (in German only) which therapeutic approaches she relies on in the fight against brain tumors and why medical progress sometimes cannot be applied immediately in treatment. For further information you may also watch the new video of the Center for Neuro-Oncology at the University Hospital Tübingen.
-
Why red wine might play a role in a future ALS therapy
A team led by Prof. Philipp Kahle discovers a basic disease mechanism of amyotrophic lateral sclerosis (ALS). Their finding: a red wine substance regulates an important enzyme and could be a therapeutic approach.
-
Call for Applications: Johannes Dichgans Doctoral Scholarship
At the Hertie Institute for Clinical Brain Research, as part of the Johannes Dichgans scholarship program, doctoral scholarships for students of human medicine will again be offered for the winter semester 2022/23.
-
Two million euros annually for brain research
The Hertie Institute for Clinical Brain Research will receive permanent funding from the State of Baden-Württemberg in the future. The institute celebrated its 20th anniversary on Wednesday, May 4, 2022 with aceremony attended by Science Minister Theresia Bauer.
See our press release for further information (in German only)
Departments
-
Neurology and Stroke
The Department of Neurology and Stroke has the main focuses in neurovascular medicine (vessel diseases of the brain, cerebral stroke), neuro-oncology (brain tumors, brain metastases), neuro-immunology (e.g., multiple sclerosis) and neuro-intensive medicine. ...more information
-
Neurodegenerative Diseases
The Department of Neurodegenerative Diseases treats in-patients on a ward of about 20 beds and in several out-patient clinics. The clinical focus lies on neurodegenerative diseases such as Parkinson’s disease, the ataxias, spastic paraplegias, and dementias. ...more information
-
Neurology and Epileptology
The Department of Neurology and Epileptology has a focus on epilepsy and other paroxysmal neurological disorders. In these diseases, the excitability of nerve cells temporarily changes either due to genetic or acquired defects. ...more information
-
Department of Neurology and Interdisciplinary Neuro-Oncology
The Department of Neurology and Interdisciplinary Neuro-oncology (Director: Prof. Ghazaleh Tabatabai) is a department covering both inpatient and outpatient clinical care... More information
-
Neural Dynamics and Magnetoencephalography
The Department of Neural Dynamics and Magnetoencephalography was founded in the year 2020 and Prof. Dr. Markus Siegel was appointed head of the department. ...more information
-
Cellular Neurology
Our research focus is on the cellular and molecular mechanisms of brain aging and age-related neurodegenerative diseases, with a special emphasis on the pathogenesis of Alzheimer´s disease and other cerebral proteopathies ...more information
-
Independent Research Groups
The independent research groups at the HIH focus on a variety of research topics ...more information
Research groups
-
Neurology and Stroke
Brain Networks and Plasticity
The human brain possesses the remarkable capacity of reorganization, which is the basis for adapting to constantly changing environmental conditions. This plasticity is of paramount importance ...more information
-
Independent Research Group
Neuropsychology of Action
The Research Group "Neuropsychology of Action" is dedicated to investigations of human action control. We study clinical impairments of action control and their neural substrates in patients with brain damage ...more information
-
Cellular Neurology
Experimental Neuroimmunology
An immune response is part of most neurological diseases, and the development of late-onset Alzheimer's Disease (AD) has been linked to immune related genes and most recently also to epigenetic modifications. ...more information
-
Neurodegenerative Diseases
Genetics of Parkinson's disease
Parkinson's syndrome (PS) is the second most common neurodegenerative disease after Alzheimer's dementia. The vast majority of patients are ill with no apparent cause. ...more information
-
Cellular Neurology
Dementia Research Unit
The Dementia Research Unit is a clinical research unit of the Department of Cellular Neurology and the Department of Psychiatry. It closely collaborates with the outpatient Memory Clinic. ...more information
-
Neurology and Epileptology
Clinical Genetics of Paroxysmal Neurological Diseases
Paroxysmal neurological disorders include a broad spectrum of clinical entities such as migraine, episodic ataxia or myotonia. The research group is focussed on the clinical genetics ...more information
-
Independent Research Group
Oculomotor Laboratory
Playing video-games is a widely distributed leisure activity in our society. In order to estimate the consequences of video-game play, we study the details of eye movements and pupil light responses ... more information
-
Cellular Neurology
Experimental Neuropathology
Cerebral proteopathy is a unifying term for cerebral neurodegenerative diseases in which aggregated proteins are abnormally deposited in the brain. The hallmark proteopathy is Alzheimer's disease (AD) ...more information
-
Independent Research Group
Molecular Brain Development
The mammalian neocortex is a highly complex and spatially heterogeneous structure, which has expanded significantly in mammalian evolution. Neocortical network function is at the heart of cognitive function ...more info
-
Neurology and Stroke
Neurological B cell Immunology
The research group “Neurological B cell Immunology” is focused on the role of B cells in neuro-inflammatory diseases including multiple sclerosis (MS) and... more information
-
Neural Dynamics and Magnetoencephalography
Neural Dynamics and Magnetoencephalography
The central goal of the laboratory is to investigate how cognition and behavior emerges from dynamic interactions across widely distributed neuronal ensembles... more information
-
Independent Research Group
Human Intracranial Cognitive Neurophysiology
The goal of the Helfrich lab is to unravel the neural network mechanisms supporting higher cognitive functions ...more info
-
Neurology and Epileptology
Experimental Neurophysiology of Channelopathies
Our research group uses transgenic mouse models to investigate the molecular mechanisms of disease-associated variants in genes encoding neuronal ion channels. ...more information
Research groups
-
Neurodegenerative Diseases
Clinical Parkinson's Disease Research
Parkinson's disease (PD) is the second most frequent neurodegenerative disorder after Alzheimer’s disease and affects about 1 to 2 % of individuals over the age of 65. The number is steadily increasing due to demographic changes in Western countries. ...more information
-
Cellular Neurology
Glia Biology Unit
Glial cells are highly abundant in the mammalian brain, yet many questions regarding their development, function, and involvement in disease remain unanswered. ...more information
-
Neurology and Stroke
Molecular Neurooncology
Three to five of 100.000 people are annually diagnosed with a glioblastoma (GBM), the most malignant brain tumor in adults. Despite aggressive multimodal treatment including surgical resection and ...more information
-
Unit
Cellular Neurology
Molecular Biomarkers Unit
Processes related to Alzheimer ́s disease (AD) and other age-related neurodegenerative diseases start many years before the onset of the first clinical symptoms. At the moment of the first clinical complaints, the disease has already caused ...more information
-
Neurology and Epileptology
Translational Imaging
The focus of our research group is the structural and functional imaging of neurological diseases with a particular focus on epileptology. We use multi-modal imaging techniques to improve the understanding of disease development ...more information
-
Neurodegenerative Diseases
Dystonia
Dystonia is the third most common movement disorder, and mutations in a growing number of genes have been identified as causes for hereditary forms in many cases. The aim of the group, which brings together clinical experience ...more information
-
Neurology and Stroke
Stroke and Neuroprotection
The research focus of our Stroke and Neuroprotection Laboratory is to find new and to optimize existing neuroprotective strategies ...more information
-
Neurology and Epileptology
Experimental Epileptology
Our research group is interested to unravel the mechanisms of well defined, mainly genetic, neurological, paroxysmal diseases, to understand correlations with clinical symptoms and to find new treatment options. ...more information
-
Independent Research Group
Active Perception Lab
Humans are tremendously reliant on the sense of vision to interact with their environment. Such interaction often involves the generation of motor outputs ...more information
-
Neurodegenerative Diseases
Mitochondrial Biology of Parkinson’s Disease
Neurodegenerative disorders are associated in a proportion of cases with genetic risk and gene mutations. However, the vast majority …more info
-
Neurology and Epileptology
Neuromuscular Imaging Group
The group works on different projects concerning nerve imaging, particularly high-resolution ultrasound in neuromuscular disorders ...more information
-
Neuro-Oncology
Laboratory for Clinical and Experimental Neuro-Oncology
The Interdisciplinary Division of Neuro-Oncology at the Hertie-Institut for Clinical Brain Research is the result of the, in the context of the Excellent Initiative, newly created W3-Professorship in Neuro-Oncology ... more information
Research groups
-
Neurology and Epileptology
Migraines and Primary Headache Disorders
Our group aims at unraveling the molecular pathophysiology of migraine and other primary headache disorders. ...more information
-
Neurodegenerative Diseases
Section for Clinical Neurogenetics
Neurogenetic diseases like cerebellar ataxia, hereditary spastic paraplegia and leukodystrophy are rare disorders. ...more information
-
Independent Research Group
Cognitive Neurology
The lab addresses a variety of topics that, at first glance, may look disparate. Yet, there is a common denominator ...more information
-
Neurodegenerative Diseases
Genomic of Rare Movement Disorders
Our group specializes in rare diseases. A disease is called rare, when it affects no more than 5 of 100,000 people. However, in the grand-scheme of things, rare diseases are not quite so rare ...more information
-
Independent Research Group
Section for Computational Sensomotorics
The Section for Computational Sensomotorics investigates theoretical principles in the perception and control of motor actions. Research is organized around three main topics ...more information
-
Independent Research Group
Section for Neuropsychology
The Section for Neuropsychology focuses on the investigation of spatial cognition and object recognition in humans. The current issues of our work comprise the action control and sensorimotor coordination ...more information
-
Neurodegenerative Diseases
Functional Neurogenetics
Age-related neurodegenerative diseases are a severe and increasingly worrisome burden for our aging population. Most of the chronic neurodegenerative diseases ...more information
-
Independent Research Group
Systems Neurophysiology Lab
The overarching goal of our work is to understand the operating principles of the neocortex, a unique brain structure, which mainly evolved in mammals. There is clear evidence that the neocortex, in the broadest sense, endows the subject with cognitive capabilities. ...more information
-
Neurodegenerative Diseases
Deep Brain Stimulation
The working group aims to uncover mechanisms of action of deep brain stimulation therapy and to translate the pathophysiological insights into future developments. …more information
-
Independent Research Group
Motor Control Modeling
The research group „Multi-Level Modeling in Motor Control and Rehabilitation Robotics“ focuses on the generation and control of active biological movements. We develop ...more information
-
Neuro-Oncology
Experimental Pediatric Neuro-Oncology
Brain tumors are the leading cause of cancer-related deaths in infants, children, and adolescents. Our lab is mostly focusing on embryonal brain tumors including ... more information
-
Independent Research Group
Neuron-Glia Interactions
The goal of the Snaidero lab is to decipher and control cellular interactions between neurons and glia cells in the cortex, focussing on the dynamic processes underlying myelination. ... more information
-
Neuro-Oncology
Health Care Research in Neuro-Oncology
The group focuses on the health-related quality of life, psychosocial burden and unmet needs in neuro-oncological patients. Our key question is... more information
-
Independent Research Group
Translational Genomics of Neurodegenerative Diseases
The translational research of our Research Division is fully geared by a systematic translational pipeline of developing therapy strategies for a broad range of genetically stratified neurodegenerative diseases ...more info
Venue: Institute of Neuroanatomy and Developmental Biology, Österbergstraße 3, 72074 Tübingen
Organizer: Deborah Kronenberg-Versteeg
More information: https://stemcellwinterschool.com
Venue: Arsenal Cinema, Hintere Grabenstraße 20, Tübingen
Start: 8:00 pm
The event is organized by Kevin Achberger (Insitute for neuroanatomy and developmental biology, University of Tübingen), Madalena Cipriano (Organ-on-Chip lab, University of Tübingen), Stefan Hauser (German Center for Neurodegenerative Diseases, Tübingen), Deborah Kronenberg-Versteeg (Hertie Institute for Clinical Brain Research, University of Tübingen), und Balazs Varga (Stem Cell Institute, University of Cambridge, UK) and supported by the Excellence Strategy of the German Federal and State Governments, the Hertie Institute for Clinical Brain Research as well as the 3R-Center Tübingen.
Combining excellent research and patient care
Click on the image to watch the video
